Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
114M
-
Shares change
-
-422K
-
Total reported value, excl. options
-
$4.58B
-
Value change
-
-$123M
-
Put/Call ratio
-
0.69
-
Number of buys
-
137
-
Number of sells
-
-125
-
Price
-
$40.26
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q1 2021
298 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q1 2021.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 114M shares
of 152M outstanding shares and own 74.91% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), Matrix Capital Management Company, LP (12.3M shares), VANGUARD GROUP INC (10M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.62M shares), BlackRock Inc. (4.9M shares), ARK Investment Management LLC (3.47M shares), GILDER GAGNON HOWE & CO LLC (2.38M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.25M shares), Neuberger Berman Group LLC (2.1M shares), and Capital International Investors (1.83M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.